Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1050: Atrial flow regulator in patients with severe primary pulmonary arterial hypertension: The AFR PROPHET registry

Presenter: Jozef Bartunek

October 28, 2025

Presentation TCT 2025

TCT 1777: Refractory HFrEF Salvaged by Atrial Flow Regulator

Presenter: Mega Febrianora

October 25, 2025

Presentation THT 2025

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

Presenter: Jozef Bartunek

February 12, 2025

Presentation THT 2023

The Occlutech AFR: Matching Shunt Length and Diameter to the Patient

Presenter: Martin Bergmann

March 20, 2023

Presentation THT 2023

The PRELIEVE trial: Final 1-year outcomes of the prospective Atrial Flow Regulator study in HFrEF and HFpEF patients and post-hoc responder analysis

Presenter: Christina Paitazoglou

March 20, 2023

Presentation TCT 2022

The PRELIEVE Study of the Atrial Flow Regulator

Presenter: Roman Pfister

September 17, 2022

Presentation TCT 2020

TCT 504: Use of Occlutech® Atrial Flow Regulator in a Single Ventricle Patient: A 3D View of a Successful Intervention

Presenter: Jenny Zablah

October 14, 2020

Presentation TCT 2019

Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator in Patients with HFrEF and HFpEF: The AFR-PRELIEVE Trial

Presenter: Felix Mahfoud

September 27, 2019

Advertisement

TCT 1050: Atrial flow regulator in patients with severe primary pulmonary arterial hypertension: The AFR PROPHET registry

TCT 1777: Refractory HFrEF Salvaged by Atrial Flow Regulator

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

The Occlutech AFR: Matching Shunt Length and Diameter to the Patient

The PRELIEVE trial: Final 1-year outcomes of the prospective Atrial Flow Regulator study in HFrEF and HFpEF patients and post-hoc responder analysis

The PRELIEVE Study of the Atrial Flow Regulator

TCT 504: Use of Occlutech® Atrial Flow Regulator in a Single Ventricle Patient: A 3D View of a Successful Intervention

Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator in Patients with HFrEF and HFpEF: The AFR-PRELIEVE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content